Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China
· Delayed Price · Currency is CNY 14.13
-0.14 (-0.98%)
May 14, 2025, 2:45 PM CST
SHE:300601 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,836 | 2,643 | 3,467 | 3,129 | 3,650 | 2,259 | Upgrade
|
| Other Revenue | 8.88 | 8.88 | 10.9 | 28.11 | 2.33 | 2.32 | Upgrade
|
| Revenue | 2,845 | 2,652 | 3,477 | 3,157 | 3,652 | 2,261 | Upgrade
|
| Revenue Growth (YoY) | -10.55% | -23.75% | 10.14% | -13.54% | 61.51% | 16.36% | Upgrade
|
| Cost of Revenue | 800 | 700.7 | 655.29 | 775.09 | 1,148 | 247.14 | Upgrade
|
| Gross Profit | 2,045 | 1,951 | 2,822 | 2,382 | 2,504 | 2,014 | Upgrade
|
| Selling, General & Admin | 1,311 | 1,253 | 1,505 | 1,315 | 819.8 | 1,030 | Upgrade
|
| Research & Development | 521.14 | 508.12 | 500.75 | 801.86 | 354.26 | 267.06 | Upgrade
|
| Other Operating Expenses | 82.49 | 30.55 | 25.62 | 20.49 | 20.16 | 14.46 | Upgrade
|
| Operating Expenses | 1,940 | 1,821 | 2,044 | 2,177 | 1,204 | 1,332 | Upgrade
|
| Operating Income | 105.74 | 129.98 | 778.26 | 205.13 | 1,300 | 682.04 | Upgrade
|
| Interest Expense | -120.83 | -124.12 | -113.71 | -108.97 | -54.51 | -2.34 | Upgrade
|
| Interest & Investment Income | 93.41 | 98.85 | 117.32 | 133.57 | 144.63 | 37.74 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.21 | 0.21 | 0 | -1.82 | -0.35 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.35 | -0.16 | -0.65 | -0.52 | -4.19 | -0.47 | Upgrade
|
| EBT Excluding Unusual Items | 82.87 | 104.76 | 781.22 | 227.38 | 1,386 | 716.96 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.6 | 1.38 | 0.19 | 3.18 | - | 30.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | -9.5 | -8.42 | -1.35 | 0.13 | 0.03 | -0.29 | Upgrade
|
| Asset Writedown | -37.58 | -15.62 | -3.32 | -624.09 | -3.41 | -5.46 | Upgrade
|
| Other Unusual Items | 75.36 | 67.84 | 163.57 | 55.15 | 56.78 | 31.06 | Upgrade
|
| Pretax Income | 111.75 | 149.94 | 940.32 | -338.25 | 1,439 | 772.41 | Upgrade
|
| Income Tax Expense | -58.16 | -51.62 | 79.02 | -205.54 | 175.87 | 93.22 | Upgrade
|
| Earnings From Continuing Operations | 169.91 | 201.55 | 861.3 | -132.71 | 1,263 | 679.19 | Upgrade
|
| Minority Interest in Earnings | 0.11 | 0.1 | - | - | - | - | Upgrade
|
| Net Income | 170.02 | 201.65 | 861.3 | -132.71 | 1,263 | 679.19 | Upgrade
|
| Net Income to Common | 170.02 | 201.65 | 861.3 | -132.71 | 1,263 | 679.19 | Upgrade
|
| Net Income Growth | -76.05% | -76.59% | - | - | 86.01% | 18.22% | Upgrade
|
| Shares Outstanding (Basic) | 1,130 | 1,120 | 1,119 | 1,106 | 1,093 | 1,055 | Upgrade
|
| Shares Outstanding (Diluted) | 1,130 | 1,120 | 1,119 | 1,106 | 1,111 | 1,076 | Upgrade
|
| Shares Change (YoY) | 2.43% | 0.15% | 1.15% | -0.43% | 3.23% | 5.34% | Upgrade
|
| EPS (Basic) | 0.15 | 0.18 | 0.77 | -0.12 | 1.16 | 0.64 | Upgrade
|
| EPS (Diluted) | 0.15 | 0.18 | 0.77 | -0.12 | 1.14 | 0.63 | Upgrade
|
| EPS Growth | -76.62% | -76.62% | - | - | 80.18% | 12.23% | Upgrade
|
| Free Cash Flow | 224.34 | 131.07 | 314.65 | -764.7 | -888.15 | -786.81 | Upgrade
|
| Free Cash Flow Per Share | 0.20 | 0.12 | 0.28 | -0.69 | -0.80 | -0.73 | Upgrade
|
| Dividend Per Share | 0.090 | 0.090 | 0.380 | - | 0.719 | 0.188 | Upgrade
|
| Dividend Growth | -76.32% | -76.32% | - | - | 283.36% | - | Upgrade
|
| Gross Margin | 71.88% | 73.58% | 81.16% | 75.45% | 68.57% | 89.07% | Upgrade
|
| Operating Margin | 3.72% | 4.90% | 22.38% | 6.50% | 35.60% | 30.16% | Upgrade
|
| Profit Margin | 5.98% | 7.61% | 24.77% | -4.20% | 34.59% | 30.04% | Upgrade
|
| Free Cash Flow Margin | 7.89% | 4.94% | 9.05% | -24.22% | -24.32% | -34.80% | Upgrade
|
| EBITDA | 443.74 | 440.66 | 979.66 | 406.08 | 1,705 | 774.97 | Upgrade
|
| EBITDA Margin | 15.60% | 16.62% | 28.17% | 12.86% | 46.69% | 34.27% | Upgrade
|
| D&A For EBITDA | 338 | 310.68 | 201.39 | 200.95 | 404.71 | 92.93 | Upgrade
|
| EBIT | 105.74 | 129.98 | 778.26 | 205.13 | 1,300 | 682.04 | Upgrade
|
| EBIT Margin | 3.72% | 4.90% | 22.38% | 6.50% | 35.60% | 30.16% | Upgrade
|
| Effective Tax Rate | - | - | 8.40% | - | 12.22% | 12.07% | Upgrade
|
| Revenue as Reported | 2,845 | 2,652 | 3,477 | 3,157 | 3,652 | 2,261 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.